Blood test could predict Alzheimer's cognitive decline risk
Summarised from 2 outlets · Updated 19 Nov, 14:13 · Archive
A blood test measuring p-tau217 protein levels could help predict whether older adults will develop cognitive decline within five to 10 years.
A Mayo Clinic study published in JAMA Neurology examined p-tau217 levels in 2,178 cognitively unimpaired adults aged 60 to 90. The researchers found that the blood test, combined with age and genetic factors, could predict cognitive decline risk. At the same elevated p-tau217 level, a 65-year-old faced a 6% estimated five-year risk of mild cognitive impairment, compared to 37% for an 85-year-old. Senior author Clifford Jack Jr., a Mayo Clinic neuroradiologist, stated the test 'tells you, just by taking a blood sample, whether someone has that pathology in the brain'.
The i Paper reports that some NHS hospitals are already offering blood tests as part of routine care ahead of formal trial completion, with wider rollout expected from early next year. University College Hospital London is currently the only British hospital doing so, though other university-linked hospitals have begun sending samples there. Dr Richard Oakley at the Alzheimer's Society said blood tests will 'widen access' and that trusts are starting conversations about funding them in dementia pathways. Blood tests are less invasive than current diagnosis methods, which require multiple hospital appointments, brain scans and lumbar puncture tests with long waiting lists, potentially reducing diagnosis time from years to days.

How it is being reported
- The simple test that will diagnose Alzheimer’s within days – available next yearWithout waiting for trials to finish, some hospitals are offering blood tests that will give people with memory problems more clarity about the futureThe i Paper · 19 Nov, 14:00
- Alzheimer’s blood marker could predict cognitive decline risks, says Mayo ClinicA Mayo Clinic study finds a p-tau217 blood test may predict cognitive decline risk within five to 10 years, offering a less invasive option than PET scans.Fox News · 18 Nov, 21:20
In this story: Mayo Clinic · JAMA Neurology · University College Hospital London · Alzheimer's Society · Clifford Jack Jr. · Fiona Carragher · Ashvini Keshavan · Richard Oakley
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)